Towards Novel Potential Molecular Targets for Antidepressant and Antipsychotic Pharmacotherapies
Authors:
- Yuriy M. KositsynYKYuriy M. Kositsyn
- Murilo S. de AbreuMAMurilo S. de Abreu
- Tatiana O. KolesnikovaTKTatiana O. Kolesnikova
- Alexey A. LaguninALAlexey A. Lagunin
- Vladimir V. PoroikovVladimir V. Poroikov
- Hasmik S. HarutyunyanHHHasmik S. Harutyunyan
- Konstantin B. YenkoyanKYKonstantin B. Yenkoyan
- Allan V. KalueffAKAllan V. Kalueff
Open Access
- 30 May 2023
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (11) , 9482
Abstract
Depression and schizophrenia are two highly prevalent and severely debilitating neuropsychiatric disorders. Both conventional antidepressant and antipsychotic pharmacotherapies are often inefficient clinically, causing multiple side effects and serious patient compliance problems. Collectively, this calls for the development of novel drug targets for treating depressed and schizophrenic patients. Here, we discuss recent translational advances, research tools and approaches, aiming to facilitate innovative drug discovery in this field. Providing a comprehensive overview of current antidepressants and antipsychotic drugs, we also outline potential novel molecular targets for treating depression and schizophrenia. We also critically evaluate multiple translational challenges and summarize various open questions, in order to foster further integrative cross-discipline research into antidepressant and antipsychotic drug development.Keywords
Funding Information
- Republic of Armenia State Committee of Science (N 10-14/23-I/YSMU, 857600)
- European Union-funded H2020 COBRAIN project (N 10-14/23-I/YSMU, 857600)
This publication has 249 references indexed in Scilit:
- The Role of Serotonin in the Regulation of Patience and ImpulsivityMolecular Neurobiology, 2012
- Towards a glutamate hypothesis of depressionNeuropharmacology, 2012
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar DepressionArchives of General Psychiatry, 2010
- Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosisSchizophrenia Research, 2010
- A Meta-Analysis of Cytokines in Major DepressionBiological Psychiatry, 2010
- Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: The role of stress and of antipsychotic treatmentSchizophrenia Research, 2010
- Interaction Between the Serotonin Transporter Gene (5-HTTLPR), Stressful Life Events, and Risk of DepressionJAMA, 2009
- Epigenomic Profiling Reveals DNA-Methylation Changes Associated with Major PsychosisThe American Journal of Human Genetics, 2008
- Antidepressant Efficacy of the Antimuscarinic Drug ScopolamineArchives of General Psychiatry, 2006
- Cytokine Production and Treatment Response in Major Depressive DisorderNeuropsychopharmacology, 2000